期刊文献+

表达禽流感病毒M2基因的重组马立克氏病病毒的构建 被引量:5

Construction of Recombinant Marek's Disease Virus Expressing M2 Gene of Avian Influenza Virus
在线阅读 下载PDF
导出
摘要 将禽流感病毒M2基因克隆于真核表达质粒pIRES-EGFP中,使其位于pCMV启动子的调控下,并与绿色荧光蛋白基因(EGFP)串联后,将上述串联基因插入到含MDV CVI988的非必需区US基因的重组质粒pUS2中,构建带标记的重组质粒,然后将此重组质粒转染感染了MDVCVI988的鸡胚成纤维细胞,利用同源重组的方法,筛选了表达禽流感病毒M2基因的重组病毒MDV1。经PCR、dot blotting,Western blotting等实验的结果表明,禽流感病毒M2基因的确插入到MDV1(CVI988)基因组中并获得表达。重组MDV1免疫1日龄SPF鸡21天后,用ELISA可检测到M2蛋白的特异性抗体。接种了重组病毒rMDV的鸡体内针对H9N2疫苗血凝素的抗体滴度(p<0.05)明显提高,以禽流感病毒AIVA/Chicken/Guangdong/00(H9N2)攻毒后进行病毒重分离试验的结果发现,重组病毒能有效地降低病毒的排出量(p<0.01),说明该重组病毒可以用于防制禽流感的免疫。 Avian influenza, caused by avian influenza virus (AIV), is a highly contiguous disease. AIV can infect almost all wild and domestic poultries and cause severe economic losses for the poultry industry. The M2 protein of AIV is a transmembrane protein. It has highly conserved antigenic epitopes and is a potential candidate antigen for avian influenza vaccine with cross-protection. Marek' s disease virus ( MDV), avian herpesvirus have mostly been used as virus vectors to express a foreign gene for the protection of chickens against poultry. Among MD vaccine viruses,attenuated MDV1 strains such as CVI988 are more suitable for be vaccine vectors because they have the closest antigenic similarity to the very virulent(vv) MDV1. To develop a recombinant herpesvirus - based AI vaccine, the M2 gene of Avian Influenza virus (AIV) ligated with green fluorescent protein (EGFP) was inserted into the US gene, which located in the nonessential region of MDV1 ( CVI988 ) genome and an EGFP marked recombinant plasmid was obtained. The M2 gene of Avian Influenza virus was expressed under the control of a CMV immediately early promoter. Through homologous recombination, this construct was transfected into cells infected with Marek' s disease virus CVI 988/Rispens and the recombinant MDV1 expressing AIV M2 gene was screened out. The PCR, dot-blot and Western blot results demonstrated that AIV M2 gene was not only cloned into the genome of MDV1 (CVI988) but also expressed. A group of one day-old chickens was injected with the recombinant virus and the specific antibody against M2 protein could be detected by ELISA after 21 days. When chickens were inoculated with commercial H9N2 subtype AI vaccine, the titers of antibody against AIV hemagglutinin from chickens inoculated with the recombinant MDVlwere higher significantly ( P 〈 0.05 ) than those of H9N2 subtype AI vaccine alone. In addition, the excretive amount of live AIV from throat and cloacae of chickens inoculated with recombinant MDV1 were less significantly ( P 〈 0.01 ) after challenged with these results indicated that the recombinant prophylactic of avian influenza. Avian influenza virus A/Chicken/ Guangdong/00 ( H9N2 ). All MDVlexpressing AIV M2 gene could be responsible for the
出处 《中国生物工程杂志》 CAS CSCD 北大核心 2007年第9期24-30,共7页 China Biotechnology
基金 国家自然科学基金资助项目(30440011)
关键词 禽流感病毒 M2基因 马立克氏病病毒 以基因重组 Avian influenza virus (AIV) M2 gene Marek's disease virus Gene recombinant
  • 相关文献

参考文献21

  • 1Calnek B W,Diseases of Poultry.11th ed.Iowa:Iowa State University Press,2003.135-159.
  • 2Takeda M,Pekosz A,Shuck K,et al.Influenza a virus M2 ion channel activity is essential for efficient replication in tissue culture.J Virol,2002,76(3):1391-1399.
  • 3Frace A M,Klimov A I,Rowe T,et al.Modified M2 proteins produce heterotypic immunity against influenza A virus.Vaccine,1999,17:2237-2244.
  • 4Gianfrani C,Oseroff C,Sidney J,et al.Human memory CTL response specific for influenza A virus is broad and multispecific.Hum Immunol,2000,61(5):438-452.
  • 5Witter R L.Attenuated revertant serotype I Marek's disease viruses:safety and protective efficacy.Avian Disease,1991(35):877-891.
  • 6Hirai K,Sakaguchi M,Maeda H,et al.Construction of recombinant Marek's desease virus type 1 expressing the lacz gene of Eschericia coli.In:The World Veterinary Poultry Association,Proceedings of 4th International Symposium on Marek's Disease Virus.19th World's Poultry Congress,Amsterdam,Holland,1992.Amsterdam:The Netherlands Veterinary Poultry Association,1992.150-155.
  • 7Witter R L.Protective efficacy of Marek's diseases vaccines.Curr Top Microbiol Immunol,2001,255:261-287.
  • 8李永清,姚四新,韦莉,杨汉春.禽流感病毒M2蛋白跨膜区基因的缺失[J].中国兽医杂志,2004,40(5):6-9. 被引量:9
  • 9李永清,杨敬,韦莉,杨汉春.禽流感病毒M2基因在原核系统中表达及其抗原性分析[J].畜牧兽医学报,2005,36(7):739-743. 被引量:5
  • 10李永清,杨敬.抗禽流感病毒M2蛋白单克隆抗体的研制.见:中国畜牧兽医学会禽病学分会.中国畜牧兽医学会禽病学分会第十二次学术研讨会论文集,中国畜牧兽医学会禽病学分会第十二次学术研讨会,中国贵阳,2004.北京:北京市农林科学院,2004.365-368.

二级参考文献31

  • 11997Slepushkin V A, Katz J M, Black R A. et al. Protection of mice against influenza A virus challenge by vaccination with baculovirus-expressed M2 protein[J]. Vaccine,1995,13(15):1399-402.
  • 2Frace A M, Klimov A I, Rowe T, et al. Modified M2 proteins produce heterotypic immunity against influenza A virus[J]. Vaccine,1999,17: 2237-2244.
  • 3Neirynck S, Deroo T, Saelens X, et al. A universal influenza A vaccine based on the extracellular domain of the M2 protein[J]. Nature Medicine. 1999,5(10):1157-63.
  • 4Henkel J R, Gibson G A, Poland P A, et al.Influenza M2 pr-oton channel activity selectively inhibits trans-Golgi network release of apical membrane and secreted proteins in polarized Madin-Darby canine kidney cells[J]. J Cell Biol,2000,148(3):495-504;149(
  • 5Boles E, Miosga T.A rapid and highly efficient method for P-CR-based site-directed mutagenesis using only one new primer[J]. Curr Genet,1995,28(2):197-198.
  • 6Andreas Urban, Susanne Neukirchen,Karl-Erich Jaeger. A r-apid and efficient method for site-directed mutagenesis using one-step overlap extension PCR A rapid and efficient method for site-directed mutagenesis using one-step overlap extension PCR[J]. Nucle
  • 7Heine H G,Boyle D B. Infectious bursal disease virus structural protein VP2 expressed by a fowl pox virus recombinant confers protection against disease in chickens[J]. Arch Virol, 1993,131(3 -4):277 - 292.
  • 8Chang H C, Lin T L, Wu C C. DNA-mediated vaccination against infectious bursal disease in chickens[J]. Vaccine, 2001, 20 (3 - 4):328 - 335.
  • 9Tsukamoto K,Takanori S, Shuji S, et al. Dual-viral vector approach induced strong and long-lasting protective immunity against very virulent infectious bursal disease virus [J]. Virology, 2000, 269:257 - 267.
  • 10Tsukamoto K,Kojima C, Komori Y, et al. Protection of chickens against very virulent infectious bursal disease virus (IBDV) and Marek's disease virus (MDV) with a recombinant MDV expressing IBDV VP2 [J]. Virology, 1999, 257(2):352-362.

共引文献14

同被引文献60

引证文献5

二级引证文献8

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部